Infant Restore: Efficacy of Microbiome Analysis and Education

Launched by SEEDING, INC DBA TINY HEALTH · May 21, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Infants are qualified for this study if they are 0 to 3 months of age at time of enrollment.
• • Infant was delivered via Cesarean delivery (C-section).
• Exclusion Criteria:
• • Infants cannot have been given probiotic supplements in their life at recruitment. This includes probiotic powder or supplements or formula with probiotic addition or multivitamin with probiotic addition.
• • Twin and multiple birth infants are not accepted in this study.
• • Infants must be full term or no less than 36-weeks gestation at delivery.
• • Infants must be residents of the United States with US postal service.
• * Infants cannot have the following existing health conditions:
• • Pre-existing gut conditions (Hirschsprung disease, eosinophilic gastrointestinal disorders (EGID) such as eosinophilic esophagitis (EoE), necrotizing enterocolitis (NEC), short bowel syndrome (SBS))
• • Immune or auto-immune conditions (severe combined immunodeficiency (SCID), human immunodeficiency virus (HIV)), excluding eczema and rashes
• • Congenital conditions (cleft lip or cleft palate, congenital heart disease, cerebral palsy, fragile X syndrome, down syndrome, spina bifida, cystic fibrosis, phenylketonuria (PKU), congenital hypothyroidism (CHT), galactosaemia)
• • Blood disorders (sickle cell disease, thalassemia, hemophilia)
• • Infants are excluded if they or any of their immediate family members have received results from an at-home microbiome stool test in the past. This does not include clinical workup such as culture or pathogen testing.

Trial Officials